Published in Am J Clin Pathol on September 01, 1988
Fungal infections in primary immunodeficiencies. Eur J Pediatr (2007) 1.37
Virulence of catalase-deficient aspergillus nidulans in p47(phox)-/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease. J Clin Invest (1998) 1.33
Emericella quadrilineata as cause of invasive aspergillosis. Emerg Infect Dis (2008) 1.05
Aspergillus quadrilineatus, a new causative agent of fungal sinusitis. J Clin Microbiol (1992) 1.05
Virulence studies of Aspergillus nidulans mutants requiring lysine or p-aminobenzoic acid in invasive pulmonary aspergillosis. Infect Immun (1994) 1.00
Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin. J Clin Microbiol (2013) 0.78
Recurrent prosthetic valve endocarditis caused by Aspergillus delacroxii (formerly Aspergillus nidulans var. echinulatus). Med Mycol Case Rep (2015) 0.75
Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) (2000) 7.17
Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol (1982) 6.78
A new genus, filobasidiella, the perfect state of Cryptococcus neoformans. Mycologia (1976) 6.24
A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A (2004) 6.21
Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med (1999) 5.82
Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol (1984) 5.74
Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol (1982) 5.40
Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun (1986) 4.91
Taxonomic studies on Filobasidiella species and their anamorphs. Antonie Van Leeuwenhoek (1982) 4.90
Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans. Mycologia (1977) 4.83
Granulocyte chemotaxis: an improved in vitro assay employing 51 Cr-labeled granulocytes. J Immunol (1973) 4.61
Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) (2000) 4.45
The p47phox mouse knock-out model of chronic granulomatous disease. J Exp Med (1995) 4.25
Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol (1994) 4.22
The regulatory role of divalent cations in human granulocyte chemotaxis. Evidence for an association between calcium exchanges and microtubule assembly. J Cell Biol (1974) 4.10
Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol (1977) 3.91
Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol Cell Biol (1990) 3.91
Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J Exp Med (1996) 3.76
Distribution of alpha and alpha mating types of Cryptococcus neoformans among natural and clinical isolates. Am J Epidemiol (1978) 3.55
Structural analysis of human neutrophil migration. Centriole, microtubule, and microfilament orientation and function during chemotaxis. J Cell Biol (1977) 3.33
Current concepts: immunology. Neutrophils in human diseases. N Engl J Med (1987) 3.29
A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes. Mycologia (1977) 3.28
Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. Science (1990) 3.15
Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect Immun (1982) 3.13
Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils. J Immunol (1985) 3.02
Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans. J Bacteriol (1982) 2.98
Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect Immun (1985) 2.91
The developmentally regulated alb1 gene of Aspergillus fumigatus: its role in modulation of conidial morphology and virulence. J Bacteriol (1998) 2.78
Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med (2001) 2.75
The second capsule gene of cryptococcus neoformans, CAP64, is essential for virulence. Infect Immun (1996) 2.67
Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet (1999) 2.63
Role of secretory events in modulating human neutrophil chemotaxis. J Clin Invest (1978) 2.59
Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways. Clin Immunol Immunopathol (1975) 2.56
Burkholderia pseudomallei infection in a Puerto Rican patient with chronic granulomatous disease: case report and review of occurrences in the Americas. Clin Infect Dis (1998) 2.53
Chromosomal rearrangement in Candida stellatoidea results in a positive effect on phenotype. Infect Immun (1991) 2.52
Creatinine metabolism in Cryptococcus neoformans and Cryptococcus bacillisporus. J Bacteriol (1980) 2.52
A developmentally regulated gene cluster involved in conidial pigment biosynthesis in Aspergillus fumigatus. J Bacteriol (1999) 2.50
Human leukocytic pyrogen induces release of specific granule contents from human neutrophils. J Clin Invest (1978) 2.48
The selective eosinophil chemotactic activity of histamine. J Exp Med (1975) 2.45
Interaction of leukocyte chemotactic factors with the cell surface. I. Chemotactic factor-induced changes in human granulocyte surface charge. J Clin Invest (1975) 2.40
Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science (1989) 2.39
Histamine type I receptor occupancy increases endothelial cytosolic calcium, reduces F-actin, and promotes albumin diffusion across cultured endothelial monolayers. J Cell Biol (1986) 2.36
Chemotactic cytokines: the role of leukocytic pyrogen and epidermal cell thymocyte-activating factor in neutrophil chemotaxis. J Immunol (1984) 2.34
Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans. Infect Immun (1992) 2.32
An inherited abnormality of neutrophil adhesion. Its genetic transmission and its association with a missing protein. N Engl J Med (1980) 2.32
Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrob Agents Chemother (1995) 2.32
Restriction fragment polymorphism in mitochondrial DNA of Cryptococcus neoformans. J Gen Microbiol (1989) 2.28
Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med (2000) 2.26
Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes. J Clin Invest (1977) 2.24
Secretory responses of human neutrophils: exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo. J Immunol (1979) 2.20
Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans. Microbiology (1994) 2.14
DNA probe for strain typing of Cryptococcus neoformans. J Clin Microbiol (1992) 2.12
Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect Immun (1998) 2.10
Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. N Engl J Med (1994) 2.07
Studies on Emmonsiella capsulata (Histoplasma capsulatum). II. Distribution of the two mating types in 13 endemic states of the United States. Am J Epidemiol (1974) 2.06
Granulocyte function in the Chediak-Higashi syndrome of mice. Blood (1974) 2.04
New, special stain for histopathological diagnosis of cryptococcosis. J Clin Microbiol (1981) 2.04
Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore) (1998) 2.03
Two forms of autosomal chronic granulomatous disease lack distinct neutrophil cytosol factors. Science (1988) 2.00
Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages. Am Rev Respir Dis (1978) 1.97
Use of lipophilic probes of membrane potential to assess human neutrophil activation. Abnormality in chronic granulomatous disease. J Clin Invest (1980) 1.97
IL-4 inhibits superoxide production by human mononuclear phagocytes. J Immunol (1990) 1.94
IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. J Immunol (1995) 1.94
Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. N Engl J Med (1989) 1.93
Serum lipids in infection. N Engl J Med (1969) 1.93
Stimulation of neutrophil oxygen-dependent metabolism by human leukocytic pyrogen. J Clin Invest (1979) 1.85
Successful treatment of Paecilomyces varioti infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections. Clin Infect Dis (1992) 1.84
Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol (1998) 1.83
Biochemical differences between serotypes of Cryptococcus neoformans. Sabouraudia (1978) 1.83
Separation and functional characterization of human neutrophil subpopulations. Blood (1978) 1.80
Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J Bacteriol (1999) 1.79
Physical and genetic mapping of Candida albicans: several genes previously assigned to chromosome 1 map to chromosome R, the rDNA-containing linkage group. Infect Immun (1991) 1.79
Rapid method to extract DNA from Cryptococcus neoformans. J Clin Microbiol (1991) 1.78
Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel of hypervirulent strain. J Infect Dis (1990) 1.77
NIH conference. Recent advances in chronic granulomatous disease. Ann Intern Med (1983) 1.76
Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio (2011) 1.76
Structural studies on the major, capsular polysaccharide from Cryptococcus bacillisporus serotype B. Carbohydr Res (1980) 1.74
Degranulating stimuli increase the availability of receptors on human neutrophils for the chemoattractant f-met-leu-phe. J Immunol (1980) 1.74
Melanogenesis in Cryptococcus neoformans. J Gen Microbiol (1988) 1.73
Cryptococcus neoformans STE12alpha regulates virulence but is not essential for mating. J Exp Med (2000) 1.71
Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. J Clin Invest (1974) 1.69
High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 1.68
Nutritional physiology and taxonomy of human-pathogenic Cladosporium-Xylohypha species. J Med Vet Mycol (1996) 1.67
On the structure of the capsular polysaccharide from Cryptococcus neoformans serotype C. Immunochemistry (1978) 1.66
Interaction of chemotactic factors with human macrophages. Induction of transmembrane potential changes. J Cell Biol (1977) 1.64
Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot Cell (2004) 1.64
Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest (1988) 1.63
Severe Burkholderia (Pseudomonas) gladioli infection in chronic granulomatous disease: report of two successfully treated cases. Clin Infect Dis (1995) 1.63
Human neutrophil-specific granule deficiency: a model to assess the role of neutrophil-specific granules in the evolution of the inflammatory response. Blood (1982) 1.62
Interaction of chemotactic factors with human polymorphonuclear leukocytes: studies using a membrane potential-sensitive cyanine dye. J Membr Biol (1980) 1.62
On the origins of congenic MATalpha and MATa strains of the pathogenic yeast Cryptococcus neoformans. Fungal Genet Biol (1999) 1.60
The differential mobilization of human neutrophil granules. Effects of phorbol myristate acetate and ionophore A23187. Am J Pathol (1977) 1.60
Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol (2003) 1.59
Production and regeneration of protoplasts from Cryptococcus. Sabouraudia (1985) 1.59
Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity. J Immunol (1982) 1.58
Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. J Infect Dis (1990) 1.55
Spleen-derived mononuclear cell chemotactic factor in malaria infections: a possible mechanism for splenic macrophage accumulation. J Immunol (1977) 1.53
Diversity of DNA fingerprints in Cryptococcus neoformans. J Clin Microbiol (1995) 1.50